We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. A deep learning model for discriminating true progression from pseudoprogression in glioblastoma patients

    Introduction

    Glioblastomas (GBMs) are highly aggressive tumors. A common clinical challenge after standard of care treatment is differentiating tumor...

    Mana Moassefi, Shahriar Faghani, ... Bradley J. Erickson in Journal of Neuro-Oncology
    Article 19 July 2022
  2. Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression

    Objectives

    We investigated the occurrence and relative contribution of relapse-associated worsening (RAW) and progression independent of relapse...

    Emilio Portaccio, Matteo Betti, ... Maria Pia Amato in Journal of Neurology
    Article Open access 28 May 2024
  3. Differentiating tumour progression from pseudoprogression in glioblastoma patients: a monoexponential, biexponential, and stretched-exponential model-based DWI study

    Background

    To investigate the diagnostic performance of parameters derived from monoexponential, biexponential, and stretched-exponential...

    Dan Liao, Yuan-Cheng Liu, ... **n-Feng Liu in BMC Medical Imaging
    Article Open access 11 September 2023
  4. Low rCBV values in glioblastoma tumor progression under chemoradiotherapy

    Purpose

    After standard treatment for glioblastoma, perfusion MRI remains challenging for differentiating tumor progression from post-treatment...

    A. Hilario, E. Salvador, ... A. Ramos in Neuroradiology
    Article 06 January 2024
  5. Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed

    Composite outcome measures such as progression-free survival and disease-free survival are increasingly used as surrogate end points in oncology...

    Anushka Walia, Jordan Tuia, Vinay Prasad in Nature Reviews Clinical Oncology
    Article 12 October 2023
  6. Endovascular coil-embolization of an unruptured, true UAA during early pregnancy- a case report

    Background

    True uterine artery aneurysms, especially during pregnancy, are a rare entity and not well understood. Clinical symptoms are unspecific...

    Kai Jannusch, Andrea Steuwe, ... Peter Minko in CVIR Endovascular
    Article Open access 23 October 2023
  7. Two sample Mendelian Randomisation using an outcome from a multilevel model of disease progression

    Identifying factors that are causes of disease progression, especially in neurodegenerative diseases, is of considerable interest. Disease...

    Michael Lawton, Yoav Ben-Shlomo, ... Kate Tilling in European Journal of Epidemiology
    Article Open access 28 January 2024
  8. Detection and agreement of event-based OCT and OCTA analysis for glaucoma progression

    Objective

    To examine event-based glaucoma progression using optical coherence tomography (OCT) and OCT angiography (OCTA).

    Methods

    In this...

    Jo-Hsuan Wu, Sasan Moghimi, ... Robert N. Weinreb in Eye
    Article 11 November 2023
  9. A clinical model to predict the progression of knee osteoarthritis: data from Dryad

    Background

    Knee osteoarthritis (KOA) is a multifactorial, slow-progressing, non-inflammatory degenerative disease primarily affecting synovial joints....

    Lianwei Shen, Shouwei Yue in Journal of Orthopaedic Surgery and Research
    Article Open access 28 August 2023
  10. Genome-wide DNA methylation analysis related to ALS patient progression and survival

    Background

    Epigenetics contributes to the pathogenesis of amyotrophic lateral sclerosis (ALS). We aimed to characterize the DNA methylation profiles...

    Tianmi Yang, Chunyu Li, ... Huifang Shang in Journal of Neurology
    Article 19 February 2024
  11. Pulmonary Fibrosis Diagnosis and Disease Progression Detected Via Hair Metabolome Analysis

    Background

    Fibrotic interstitial lung disease is often identified late due to non-specific symptoms, inadequate access to specialist care, and...

    Hunter A. Miller, Sally Suliman, Hermann B. Frieboes in Lung
    Article 11 June 2024
  12. Coil Embolization of True, Common and Proper, Hepatic Artery Aneurysms: Technique, Safety and Outcome

    Purpose

    To retrospectively assess the safety and efficacy of coil embolization for catheter-directed true common and proper hepatic artery aneurysm...

    A. Van Holsbeeck, E. Dhondt, ... G. Maleux in CardioVascular and Interventional Radiology
    Article 14 March 2023
  13. Predictors of progression of multiple sclerosis in a sample of Egyptian patients

    Background

    Multiple sclerosis (MS) is a multifactorial neurodegenerative autoimmune disease with a varied clinical course and presentation, which is...

    Manar A. Shawky, Tarek I. Menecie, ... Mohammed H. Rashad in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 03 January 2024
  14. Pursuing Clinical Predictors and Biomarkers for Progression in ILD: Analysis of the Pulmonary Fibrosis Foundation (PFF) Registry

    Introduction

    Pulmonary fibrosis is a characteristic of various interstitial lung diseases (ILDs) with differing etiologies. Clinical trials in...

    Sarah E. Chang, Guiquan Jia, ... Margaret Neighbors in Lung
    Article Open access 16 May 2024
  15. WDR1 promotes prostate cancer progression through Wnt/β-catenin signaling

    Prostate cancer (PCa) is the second most common cancer and the fifth leading cause of cancer-related death among men. A comprehensive understanding...

    **feng Cheng, Dan Huo, ... Yanjun Lu in Medical Oncology
    Article 14 May 2024
  16. Integrated FDG-PET/CT contribution over cross-sectional imaging in recurrence or progression of pancreaticobiliary neoplasms

    Purpose

    We aim to compare FDG-PET/CT and cross-sectional imaging (contrastenhanced CT/MRI) diagnostic abilities in detecting recurrence/progression of...

    Banu Karaalioglu, Tansel Cakir, ... Ahmet Bilici in Abdominal Radiology
    Article 22 November 2023
  17. Keratectasia severity staging and progression assessment based on the biomechanical E-staging

    Until recently, corneal topography has been the gold standard in detecting keratectasia and monitoring its progression. The recently introduced ABCD...

    Elias Flockerzi, Berthold Seitz in Eye and Vision
    Article Open access 01 July 2024
  18. Alternative splicing in prostate cancer progression and therapeutic resistance

    Prostate cancer (CaP) remains the second leading cause of cancer deaths in western men. CaP mortality results from diverse molecular mechanisms that...

    Chitra Rawat, Hannelore V. Heemers in Oncogene
    Article Open access 24 April 2024
  19. Sodium and water dynamics in the progression of chronic kidney disease: mechanisms and clinical significance

    Aim

    Lifestyle modifications can postpone the progression of chronic kidney disease toward its terminal stage. This mini-review aims to explore the...

    Nereida Spahia, Merita Rroji, ... Myftar Barbullushi in International Urology and Nephrology
    Article 10 January 2024
  20. Can blood-based markers predict RECIST progression in non-small cell lung cancer treated with immunotherapy?

    Purpose

    In this study, we aimed to evaluate the potential of routine blood markers, serum tumour markers and their combination in predicting...

    Melda Yeghaian, Teresa M. Tareco Bucho, ... Stefano Trebeschi in Journal of Cancer Research and Clinical Oncology
    Article Open access 26 June 2024
Did you find what you were looking for? Share feedback.